VidistarViewer
Published by:
VidiStar
Description
VidistarViewer™ offers medical professionals instant access to their medical images and reports from their mobile Apple device(s). With VidistarViewer™, users may view still images, video clips, patient information, diagnostic reports, and review their diagnostic DICOM studies (i.e. echos, vascular studies, OBGYN, nuclear, cath, angio, etc.).
Review Studies from Anywhere
VidistarViewer™ includes similar functionality to VidiStar's web-solutions, and allows users to review studies and reports regardless of location.
Engage Your Patients
Use your iPad to show your patient their diagnostic study and enhance their engagement in their plan of care by educating them on their condition, thus heightening their understanding and furthering your patient-relationship.
Hide
Show More...
Review Studies from Anywhere
VidistarViewer™ includes similar functionality to VidiStar's web-solutions, and allows users to review studies and reports regardless of location.
Engage Your Patients
Use your iPad to show your patient their diagnostic study and enhance their engagement in their plan of care by educating them on their condition, thus heightening their understanding and furthering your patient-relationship.
Screenshots
VidistarViewer FAQ
-
Is VidistarViewer free?
Yes, VidistarViewer is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is VidistarViewer legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does VidistarViewer cost?
VidistarViewer is free.
-
What is VidistarViewer revenue?
To get estimated revenue of VidistarViewer app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Italy yet.
Ratings History
VidistarViewer Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Free
|
|
478
|
VidistarViewer Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
ResolutionMD
|
View
|
View
|
0
|
|
10 months ago | |
iDO Viewer
|
View
|
View
|
0
|
|
1 year ago | |
mRay
|
View
|
View
|
0
|
|
1 month ago | |
MobiPACS Pro
|
View
|
View
|
0
|
|
1 year ago | |
MobiPACS Lite
|
View
|
View
|
0
|
|
1 year ago | |
Rad@ VP
|
View
|
View
|
0
|
|
2 years ago | |
dicom.link CloudPACS Client
Mobile DICOM viewer and more
|
View
|
View
|
0
|
|
3 years ago | |
Aidoc
|
View
|
View
|
0
|
|
1 month ago | |
UDE Lite
DICOM Server, Viewer & Display
|
View
|
View
|
0
|
|
1 month ago | |
aycan mobile
|
View
|
View
|
0
|
|
1 year ago |
VidistarViewer Installs
Last 30 days
VidistarViewer Revenue
Last 30 daysVidistarViewer Revenue and Downloads
Gain valuable insights into VidistarViewer performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- VidiStar
- Languages
- English
- Recent release
- 2.3.0 (9 months ago )
- Released on
- Jan 26, 2013 (11 years ago )
- Also available in
- United States, Canada, Poland, South Korea, Kuwait, Kazakhstan, Lebanon, Mexico, Portugal, Malaysia, Nigeria, Netherlands, Norway, New Zealand, Peru, Philippines, Japan, Pakistan, India, Romania, Russia, Saudi Arabia, Sweden, Singapore, Slovenia, Thailand, Türkiye, Taiwan, Ukraine, Vietnam, South Africa, Dominican Republic, Argentina, Austria, Australia, Azerbaijan, Belgium, Brazil, Belarus, Switzerland, Chile, China, Colombia, Czechia, Germany, Denmark, Italy, Algeria, Ecuador, Egypt, Spain, Finland, France, United Kingdom, Greece, Hong Kong SAR China, Hungary, Indonesia, Ireland, Israel, United Arab Emirates
- Last Updated
- 1 week ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.